Mrs Joyce R Dion, MSW | |
49 School Street, Hartford, VT 05047 | |
(802) 295-3031 | |
(802) 295-0820 |
Full Name | Mrs Joyce R Dion |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 49 School Street, Hartford, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699850115 | NPI | - | NPPES |
1012543 | Medicaid | VT | |
69330 | Other | VT | BLUE CROSS/BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 0890001116 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Joyce R Dion, MSW 49 School Street, Hartford, VT 05047 Ph: (802) 295-3031 | Mrs Joyce R Dion, MSW 49 School Street, Hartford, VT 05047 Ph: (802) 295-3031 |
News Archive
Emerson Ecologics, LLC announces the debut of the first group of manufacturers to be awarded Partner status in the Emerson Quality Program(SM) (EQP). This one-of-a-kind quality assurance program for the nutritional supplements industry provides practitioners with manufacturer-specific quality and safety information to assist in confidently recommending the best products to patients.
Do you get impulsive when you're upset? If so, this could be putting you at risk for binge eating. According to Kelly Klump, professor of psychology at Michigan State University and senior author, the more impulsive you are, the more likely it is you'll binge eat when experiencing negative feelings.
Applied relaxation techniques could help postmenopausal women significantly reduce the number of hot flashes they experience each day, research suggests.
Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application (ANDA) for generic version of FLOMAX® (tamsulosin hydrochloride) 0.4mg capsules. Boehringer Ingelheim Pharmaceuticals, Inc. markets FLOMAX® for the functional symptoms of benign prostatic hyperplasia.
Exelixis, Inc. today announced the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for COMETRIQ (cabozantinib) for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).
› Verified 7 days ago
Christina Lynne Key, MSW LCSW LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 49 School Street, Hartford, VT 05047 Phone: 802-295-3031 Fax: 802-295-0820 | |
Gretchen L Van Winkle, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 49 School Street, Hartford, VT 05047 Phone: 802-295-3031 Fax: 802-295-8020 | |
Leda M. Rodis, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 49 School Street, Hartford, VT 05047 Phone: 802-295-3032 Fax: 802-295-0820 | |
Kristin A Reifenrath, MSW, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 49 School Street, Hartford, VT 05047 Phone: 802-295-3031 Fax: 802-295-0820 | |
Heather Hildebrant, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 49 School St, Hartford, VT 05047 Phone: 802-295-3031 Fax: 802-295-0820 |